logo

Moehs group will be represented at CPHI South East Asia, which will be held from 12 to 14 March in Bangkok (Thailand)

Moehs group will be represented at CPHI South East Asia, which will be held from 12 to 14 March in Bangkok (Thailand)

Leave a Comment / By

In 2019, CPhI South East Asia will be held at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand (12-14 March).

Moehs group, in its international presence, will be represented by its local agent Asia Drug in the most important fair of the pharmaceutical industry in Indonesia and throughout Southeast Asia.

In this event, new trends and innovations are presented, networks are built and contacts are established that achieve long-term business relationships.

The main Indian and Southeast Asian suppliers of pharmaceutical ingredients and services within the sector will be present at this meeting.

When?

From March 12 to 14, 2019

Where to find us?

Visit us at STAND LB7 + LB11

Do you want to contact?

Contact us for any information and appointments at: info@moehs.es

 

Leave a Comment

Your email address will not be published. Required fields are marked *

logo
Twitter Linkedin-in
  • Headquarters:
  • Pol. Ind. Cova Solera
  • c/Roma, 8-12 08191 Rubí.
  • Barcelona (Spain)
  • T +34 93 586 05 20
  • Fax +34 93 588 85 13
  • info@moehs.es

Partnering companies

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF A STIMULATOR ACTIVE PRINCIPLE OF SOLUBLE CYCLASE GUANYLATE by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of an active ingredient that stimulates soluble guanylate cyclase.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2024 and they have a financeable budget of €1,862,213.00.
This project is co-financed by the European Union and CDTI.

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF AN ACTIVE INHIBITOR PRINCIPLE OF JANUS KINASE FOR THE TREATMENT OF ATOPIC DERMATITIS.”, by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2025 and they have a financeable budget of €1,940,409.
This project is co-financed by the European Union and CDTI.